VOMISETRON tab

Composition:

Each film coated tablet contains: Granisetron HCL 1.12 mg equivalent to Granisetron.

Indications:

VOMISETRON  is indicated for the prevention of:

• Nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin.
• Nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation.

Dosage:

Emetogenic chemotherapy:

The recommended adult dosage of VOMISETRON  is 2 mg once daily or 1 mg twice daily. In the 2 mg once-daily regimen, two 1 mg tablets are given up to 1 hour before chemotherapy. In the 1 mg twice daily regimen, the first 1 mg tablet is given up to 1 hour before chemotherapy, and the second tablet, 12 hours after the first .

Use in the elderly, pediatric patients, renal failure patients or hepatically impaired patients:

No dosage adjustment is recommended.

Radiation ( either total body irradiation or fractionated abdominal radiation):

The recommended adult dosage of VOMISETRON  is 2 mg once daily. Two 1 mg tablets are taken within 1 hour of radiation.

Pediatric use:

There is no experience with oral VOMISETRON  in the prevention of radiation induced nausea and vomiting in pediatric patients.

Use in the elderly:

No dosage adjustment is recommended.

Package:

VOMISETRON  film coated tablet: Box of 10 film coated tablets.